Update on Antiepileptic Drugs 2019
Author:
- Bassel W. Abou-KhalilBABassel W. Abou-Khalil
- 1 April 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Continuum
- Vol. 25 (2) , 508-536
Abstract
PURPOSE OF REVIEWThis article is an update from the article on antiepileptic drug (AED) therapy published in the last Continuum issue on epilepsy and is intended to cover the vast majority of agents currently available to the neurologist in the management of patients with epilepsy. TreatmentKeywords
This publication has 87 references indexed in Scilit:
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registryThe Lancet Neurology, 2018
- The clinical pharmacology of traditional antiepileptic drugsEpileptic Disorders, 2014
- Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective studyJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Comparative safety of antiepileptic drugs during pregnancyNeurology, 2012
- Comparison and predictors of rash associated with 15 antiepileptic drugsNeurology, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsyEpilepsy Research, 1999
- A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsyEpilepsy Research, 1989
- Comparison of oxcarbazepine and carbamazepine: a double-blind studyEpilepsy Research, 1987
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985